S3065
SC 19220
≥98% (HPLC), solid
别名:
2-乙酰肼 10 (11H)-羧酸, 8-氯代二苯 [b,f] [1,4] 恶嗪-10 (11H)-羧酸
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C16H14N3O3Cl
化学文摘社编号:
分子量:
331.75
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
产品名称
SC 19220, ≥98% (HPLC), solid
InChI
1S/C16H14ClN3O3/c1-10(21)18-19-16(22)20-9-11-4-2-3-5-14(11)23-15-7-6-12(17)8-13(15)20/h2-8H,9H2,1H3,(H,18,21)(H,19,22)
SMILES string
CC(=O)NNC(=O)N1Cc2ccccc2Oc3ccc(Cl)cc13
InChI key
KNURFLJTOUGOOQ-UHFFFAOYSA-N
assay
≥98% (HPLC)
form
solid
color
white
mp
190-191 °C (lit.)
solubility
DMSO: soluble 10 mg/mL
H2O: insoluble
Quality Level
Gene Information
human ... PTGER1(5731)
rat ... Ptger1(25637)
Application
采用 SC 19220 研究前列腺素 E 2 在大鼠皮质培养物中氧糖剥夺诱导的神经毒性和预处理诱导的神经保护中的作用。
Biochem/physiol Actions
EP 1 前列腺素受体拮抗剂
SC 19220 是前列腺素 E 受体的竞争性拮抗剂。它与 PGE 2 竞争调节膀胱尿道运动，并增加大鼠膀胱容量。它能抑制平滑肌对前列腺素 E 2 和 F 2α 的收缩反应。SC 19220 还可抑制维生素 D3、甲状旁腺激素、IL-11 和 IL-6 诱导的破骨细胞的形成。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Alexander V Timoshenko et al.
Experimental cell research, 289(2), 265-274 (2003-09-23)
Aberrant upregulation of COX-2 enzyme resulting in accumulation of PGE2 in a cancer cell environment is a marker for progression of many cancers, including breast cancer. Four subtypes of cell surface receptors (EP1, EP2, EP3, and EP4), which are coupled
H Inoue et al.
The Journal of endocrinology, 161(2), 231-236 (1999-05-13)
1,25 Dihydroxy vitamin D3 (1,25(OH)2D3), prostaglandin (PG) E2 and parathyroid hormone (PTH) induce osteoclast formation in cell cultures. Previously, we have shown that SC-19220, an antagonist of the EP1 subtype of PGE receptors, inhibited tartrate-resistant acid phosphatase (TRAP)-positive cell formation
Xavier Norel et al.
British journal of pharmacology, 142(4), 788-796 (2004-06-03)
1. In human pulmonary vascular preparations, precontracted arteries were more sensitive to the relaxant effect of acetylcholine (ACh) than veins (pD(2) values: 7.25+/-0.08 (n=23) and 5.92+/-0.09 (n=25), respectively). Therefore, the role of prostacyclin (PGI(2)) was explored to examine whether this
C A Maggi et al.
European journal of pharmacology, 152(3), 273-279 (1988-08-02)
SC-19220 (5-20 mg/kg i.v.), a competitive receptor antagonist of PGE, increased the bladder capacity and reduced the voiding efficiency of micturition (elicited by slow transvesical filling) of urethane-anesthetized rats. The effect of SC-19220 was prevented by indomethacin pretreatment, whereas indomethacin
K Oka et al.
The American journal of physiology, 275(6 Pt 2), R1762-R1765 (1998-12-09)
We have previously reported that central injection of PGE2 induces hyperthermia through its actions on EP1 receptors in rats. Because the increase in local synthesis of PGE2 is assumed to be a necessary process in a fever caused by central
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持